Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector
Sort by: Date|Relevance

Myovant Sciences Shares Rise on NDA Filing for Uterine Fibroid Combination Therapy Drug

Shares of Myovant Sciences traded 40% higher after the company reported that it has submitted a New Drug Application to the FDA for once-daily relugolix combination tablet for the treatment of women with uterine fibroids. Healthcare company Myovant Sciences Ltd. (...
Streetwise Reports | June 2, 2020 |

Women's Wellness Device Developer Posts In-Line Quarter, Catalysts Looming

A review of this Colorado company's first numbers of the year was provided in a Ladenburg Thalmann report. In a May 13 research note, Ladenburg Thalmann analyst Jeffrey Cohen reported that Viveve Medical Inc.'s (VIVE:NASDAQ) Q1/19 "reads fine." Q1/19 rev...
Streetwise Reports | May 16, 2019 |

US Biopharma to Launch Phase 3 Trial in Bacterial Vaginosis

Daré Bioscience's study, its prospects and the indication's U.S. market opportunity are discussed in a ROTH Capital Partners report. In a May 15 research note, ROTH Capital Partners analyst Yasmeen Rahimi reviewed why the outlook is positive for Daré Bioscience In...
Streetwise Reports | May 21, 2020 |

Aben Resources Expands Footprint in the Golden Triangle

Aben Resources (TSX.V: ABN | OTCQB: ABNAF ) In this exclusive interview, James Pettit of Aben Resources sits down with Maurice Jackson of Proven and Probable to discuss the latest drill results for the North Boundary Zone on the f...
Maurice Jackson | September 27, 2019 |

Poised for a Huge Bounce: Canada’s Most Technologically Advanced LP

While some cannabis companies struggle with the emerging Canadian market, others are showing they know exactly how to make it work. The cannabis companies that are making it in are playing it smart, recognizing where the market is at and where it’s going, an...
Cindy Broad | February 12, 2020 |

Skechers Puts its Best Foot Forward with Record Quarterly Sales

Skechers USA reported record global sales for the second quarter. International sales led the way in the quarter with an increase of 19.8% over the same period last year. Lifestyle and performance footwear company Skechers USA Inc. (SKX:NYSE) reported ...
Streetwise Reports | July 22, 2019 |

Klondike Golden Moments

Foreword: This tale grew from a chance nugget discovery along the shore of a humble Yukon creek carving through the remote Territory and became the great history of the Klondike Gold Rush. Join author James Kwantes as he touches down in the Yukon with 12 exciting stories and c...
James Kwantes | August 15, 2019 |

Crescat Gets Activist on Gold #1

We have been hard at work negotiating deals in select gold and silver exploration companies. In our hedge funds, we have been investing in private placements in public companies, often at significant discounts with warrants. We are building activist positions in some the...
Featured Submission | June 26, 2020 |

Immuno-oncology Firm to Co-Develop Companion Diagnostic for Cervical Dysplasia

The partnership news and upcoming data readouts are reviewed in an H.C. Wainwright & Co. report. In a May 17 report, H.C. Wainwright & Co. analyst Ram Selvaraju reported that Inovio Pharmaceuticals Inc. (INO:NASDAQ) will collaborate with QIAGEN, a molecula...
Streetwise Reports | May 27, 2019 |

Biotech Firm ''Creating Innovative Solutions' for Female Health

The company's most advanced assets are discussed in a Dawson James Securities report. In a July 18 research note, Dawson James Securities analyst Jason Kolbert reported he assumed coverage on Daré Bioscience Inc. (DARE:NASDAQ) , and in doing so, rated it Bu...
Streetwise Reports | July 24, 2019 |
1 2 3 4 5 6 7 8 9 10